Latest CSL News | Page 2

CSL statement on COVID19 Vaccine Manufacture
CSL Notice of Full Year Results Announcement
At White House Roundtable, Paul Perreault Urges People to Donate Plasma in Fight Against COVID-19
Newcastle: Bulk carrier detained after seafarers intimidated, underpaid and forced to sail for
Partnership to progress treatments for Sjogren’s syndrome
CSL statement in Response to Inaccurate Courier Mail Report About Agreement for Queensland COVID-19 Vaccine Supply
Inaccurate Report of COVID-19 Vaccine Agreement
Close-ups of Sun
Rare Diseases in Asia-Pacific
UQ COVID 19 Vaccine to Commence Human Trials
Dosing begins in first human trial of UQ COVID-19 vaccine
Human trials begin on world-leading COVID-19 vaccine in Qld
CSLBehring Gene Therapy Agreement with uniQure
David Lamont appointed Chief Financial Officer
UQ moves up in world top 50 rankings
UQ holds strong in world top 50 rankings
Global manufacturing deal signed for Qld coronavirus vaccine
Government welcomes UQ’s COVID-19 vaccine candidate
UQ, CEPI and CSL partner for COVID-19
University of Queensland, CEPI and CSL partner to advance development and manufacture of COVID-19 vaccine candidate
Australian Government invests in new medicines for COVID-19
2021 CSL Centenary Fellowships
One million additional flu vaccines to roll out in next three weeks
Racing against time, medical researchers, life science companies and COVID-19 survivors launch national campaign
Australia’s top scientists elected as Fellows of Academy 25 May
Development of COVID-19 immunoglobulin commences
COVID-19: Potentially lifesaving immunoglobulin treatment for seriously ill Australians
Stepping up flu vaccine supply – Seqirus to supply additional two million flu vaccines to Australia
CSL Behring and SAB Biotherapeutics Join Forces
Collaborating on Potential COVID-19 Therapy
CSL’s Global Role in Battling COVID-19
Setting record straight on a sustainable gambling industry
Taskforce To Help Shape Victoria’s Innovation Agenda
CSL statement on Coronavirus
MTPConnect to Drive Workforce Growth Through New REDI Program
CSL Ranks Among Best Employers for Diversity
Center of Excellence in Industrial Biotechnology seeks seed grant proposals
CSL Continues to Advance R&D Capabilities
NBN Board Changes
Paul Perreault Named Among Best Performing CEOs
CSL Limited Celebrates 25 Years on ASX
$2.5 million CSL Centenary Fellowships announced
CSL to Move Global Headquarters
CSL Renews Partnership with NYSF
CSL at J.P. Morgan’s 2019 Healthcare Conference
Nancy Millis building opens at Bio21 Institute
Developments in cell-based vaccine technology